Guillain-Barré-Strohl syndrome and COVID-19: Case report and literature review

Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China2020. https://doi.org/10.1001/jamaneurol.2020.1127.

Toscano, 2020, Guillain–Barré syndrome associated with SARS-CoV-2, N Engl J Med, 10.1056/NEJMc2009191

Van Den Berg, 2014, Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis, Nat Rev Neurol, 10, 469, 10.1038/nrneurol.2014.121

Sejvar, 2011, Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data, Vaccine, 29, 599, 10.1016/j.vaccine.2010.06.003

Gigli, 2020, Guillain-Barré syndrome in the COVID-19 era: just an occasional cluster?, J Neurol, 10.1007/s00415-020-09911-3

Kim, 2017, Neurological complications during treatment of middle east respiratory syndrome, J Clin Neurol, 13, 227, 10.3988/jcn.2017.13.3.227

Sharma, 2019, Guillain–Barré syndrome with unilateral peripheral facial and bulbar palsy in a child: a case report, SAGE Open Med Case Reports, 7, 10.1177/2050313X19838750

Baig, 2020, Evidence of the COVID-19 virus targeting the cns: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms, ACS Chem Neurosci, 11, 995, 10.1021/acschemneuro.0c00122

Alberti, 2020, Guillain-Barré syndrome related to COVID-19 infection, Neurol Neuroimmunol Neuroinflamm, 7, 1, 10.1212/NXI.0000000000000741

Andrea, 2020, New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases, Neurol Sci

Camdessanche, 2020, COVID-19 may induce Guillain–Barré syndrome, Rev Neurol (Paris)

Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S, San E, Murillo P, Bermejo-Guerrero L, et al. Miller Fisher Syndrome and polyneuritis cranialis in COVID-192020. https://doi.org/10.1212/WNL.0000000000009619.

Lascano, 2020, SARS‐CoV‐2 and Guillain‐Barré syndrome: AIDP variant with favorable outcome, Eur J Neurol, 10.1111/ene.14368

Padroni, 2020, Guillain-Barré syndrome following COVID-19: new infection, old complication?, J Neurol, 1

Rana, 2020, Novel coronavirus (COVID-19)-associated Guillain-Barré syndrome: case report, J Clin Neuromuscul Dis, 21, 240, 10.1097/CND.0000000000000309

Scheidl, 2020, Guillain-Barre syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature, J Peripher Nerv Syst, 10.1111/jns.12382

Virani, 2020, Guillain-Barré syndrome associated with SARS-CoV-2 infection, IDCases, 20, 10.1016/j.idcr.2020.e00771

Zhao, 2020, Correspondence, Lancet Glob Heal, 4422, 2

Oguz‐Akarsu, 2020, Guillain–Barré syndrome in a patient with minimal symptoms of COVID‐19 infection, Muscle Nerve, 10.1002/mus.26992

Helbok, 2020, Guillain‐Barré syndrome in a patient with antibodies against SARS‐COV‐2, Eur J Neurol, 10.1111/ene.14388

Bigaut, 2020, Guillain-Barré syndrome related to SARS-CoV-2 infection, Neurol Neuroimmunol Neuroinflamm, 7, 2, 10.1212/NXI.0000000000000785

Ottaviani D, Boso F, Tranquillini E, Gapeni I, Pedrotti G, Cozzio S, et al. Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci2016:1–4. https://doi.org/10.1007/s10072-020-04449-8.

Parra, 2016, Guillain-Barré syndrome associated with Zika virus infection in Colombia, N Engl J Med, 375, 1513, 10.1056/NEJMoa1605564

Fantini, 2020, Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection, Int J Antimicrob Agents, 55, 10.1016/j.ijantimicag.2020.105960